← Leaderboards
Jacob Bode
Eurofins Panlabs, Inc.
$2,367,927
Attributed
$2,367,927
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $526.2K · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,367,927 · 2
By mechanism
N01$2,367,927 · 2
Top collaborators
No co-investigators on record.
Most similar at Eurofins Panlabs, Inc.
Same institution · by research overlap
- Bryan Koci$3,480,946
- Anthony Gallagher$389,300
- Anthony Gallacher$585,330
- N N$12,000
- David Dean$18,273
Others in their field
Other Emerging Leaders on “Programs”
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$348,328,584
- Lynn Briscoe · Leidos Biomedical Research, Inc.$312,382,073
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
ProgramsPre-ClinicalIn VitroToxicologyServicesEvaluationSafetyInterventional Agent DevelopmentToxinPathogenScreeningChemistryTherapeutic DevelopmentCommunicable DiseasesIn VivoDevelopment PlansLeadDrug KineticsProduct DevelopmentLead OptimizationSupport ContractsMicrobiologyRodentAntimicrobial Resistance
Grant awards (19)
Task E14: Lead Optimization Screening Assays for ADMET, Safety Profiling, Rodent Pharmacokinetics and MTD$232,504
N01 · FY2024 · AI · contact PI
Task E14: Lead Optimization Screening Assays for ADMET, Safety Profiling, Rodent Pharmacokinetics and MTD$127,980
N01 · FY2024 · AI · contact PI
Task E14: Lead Optimization Screening Assays for ADMET, Safety Profiling, Rodent Pharmacokinetics and MTD$85,320
N01 · FY2024 · AI · contact PI
Task B31: Bulk Intermediate Scaleup for Antibiotic-Resistant Drug Design$67,783
N01 · FY2024 · AI · contact PI
TASK ORDER 07 (75N95022F00001) FOR IDIQ HHSN271201800024I WITH EUROFINS PANLABS DISCOVERY SERVICES$224,328
N01 · FY2022 · DA · contact PI
Task E08: Lead Optimization Screening Assays for ADMET and Safety Profiling$214,774
N01 · FY2021 · AI · contact PI
Task E08: Lead Optimization Screening Assays for ADMET and Safety Profiling$88,269
N01 · FY2021 · AI · contact PI
Task E07: Screening of Rodent Pharmacokinetics for Lead Optimization$51,849
N01 · FY2021 · AI · contact PI
Task E07: Screening of Rodent Pharmacokinetics for Lead Optimization$34,564
N01 · FY2021 · AI · contact PI
Task E08: Lead Optimization Screening Assays for ADMET and Safety Profiling$29,422
N01 · FY2021 · AI · contact PI
FY20. RECEPTOR PROFILES - TASK ORDER NO. 75N95020F00159 POP: SEPTEMBER 30, 2020 - SEPTEMBER 29, 2021. N01DA-18-8937.$359,131
N01 · FY2020 · DA · contact PI
Task E07: Screening of Rodent Pharmacokinetics for Lead Optimization$69,120
N01 · FY2020 · AI · contact PI
Task E07: Screening of Rodent Pharmacokinetics for Lead Optimization$43,200
N01 · FY2020 · AI · contact PI
Task E04: SCREENING OF RODENT PHARMACOKINETICS FOR LEAD OPTIMIZATION$22,500
N01 · FY2020 · AI · contact PI
Task E07: Screening of Rodent Pharmacokinetics for Lead Optimization$17,280
N01 · FY2020 · AI · contact PI
Task E04: SCREENING OF RODENT PHARMACOKINETICS FOR LEAD OPTIMIZATION$15,000
N01 · FY2020 · AI · contact PI
Task E03: Lead Optimization Screening Assays for Safety Profiling$102,981
N01 · FY2019 · AI · contact PI
Task E04: SCREENING OF RODENT PHARMACOKINETICS FOR LEAD OPTIMIZATION$75,000
N01 · FY2019 · AI · contact PI
Task E01: Lead Optimization Screening Assays for ADME, Safety, and PK Properties$506,922
N01 · FY2018 · AI · contact PI